Biology Reference
In-Depth Information
Table 5.2
(continued)
Subjects
Isoform
Dose and route
Results
References
Kisspeptin-10
20-720 pmol/kg/min IV ×30 min, then half
rate ×60 min (cumulative
dose 1.2-43.2 nmol/kg)
No clear responses to kisspeptin were seen in early
to mid-follicular women
[
14
]
Kisspeptin-54
1 nmol/kg IV ×1
LH rose gradually across the 3-h study in early to
mid-follicular women
[
14
]
Kisspeptin-54
0.2-6.4 nmol/kg SC ×1
LH rose across the study in a biphasic pattern, with
small responses in early to mid-follicular
women, larger responses in mid-luteal women,
and very large responses in preovulatory
women
[
15
]
Women
with hypothalamic
amenorrhea
Kisspeptin-54
6.4 nmol/kg SC twice daily ×2 week
LH rose after initial exposure to kisspeptin, but this
response decreased over days
[
43
,
63
]
Kisspeptin-54
6.4 nmol/kg SC twice weekly ×8 week
LH rose after initial exposure to kisspeptin and
continued to respond to kisspeptin (but
decreased partially) across the 8-week study
period; no folliculogenesis or ovulation was
observed
[
63
]
Men and women with
mutations in the
neurokinin B pathway
Kisspeptin-10
1.1 nmol/kg/h ×8 h
LH pulse amplitude increased
[
45
]
IV
intravenously;
SC
subcutaneously
Search WWH ::
Custom Search